Medical/Pharmaceuticals
Geneos Therapeutics Initiates IMPACT31 Phase 2 Randomized Clinical Trial Evaluating Neoantigen-Targeted Personalized DNA Immunotherapy for Cancer
* The study evaluates patients with liver cancer at high risk of recurrence following surgical resection * Julie Rosenberg, MD, appointed to leadership team as Chief Medical Officer PHILADELPHIA, Oct. 21, 2026 /PRNewswire/ -- Geneos Therapeutics, a clinical stage biotherapeutics company focus...
2026-10-21 21:10
4657
Akeso Announces Summit Therapeutics and ECOG-ACRIN Cancer Research Group Enter into Phase II/III Clinical Trial Collaboration to Evaluate Ivonescimab in First-Line Biliary Tract Cancer
* Becomes the 7th International Registrational Clinical Trial for Ivonescimab * Clinical Trial Site Activations in the United States Expected to Begin Q4 2026 HONG KONG, Oct. 21, 2026 /PRNewswire/ -- Akeso, Inc. (HKEX: 9926.HK) today announced that Summit Therapeutics Inc. (NASDAQ: SMMT), its ...
2026-10-21 20:42
2607
Axtria Wins 2026 Minsky Award for Excellence in AI for the Third Consecutive Year
AI-powered Next Best Action solution generated more than $180 million in
incremental revenue for a brand for a global pharmaceutical leader
BERKELEY HEIGHTS, N.J., Oct. 21, 2026 /PRNewswire/ -- Axtria Inc.
2026-10-21 20:15
2320
China SXT Pharmaceuticals Inc Announces Termination of Additional Purchase Right
TAIZHOU, China, Oct. 21, 2026 /PRNewswire/ -- China SXT Pharmaceuticals Inc. (NASDAQ: SXTC) (the "Company"),today announced that it has entered into a termination letter agreement with the purchasers in its registered direct offering announced on October 8, 2026 (the "Offering"). Under the termi...
2026-10-21 20:00
4500
ESTEVE CDMO expands its presence in Asia with a major investment and new manufacturing site in China
* After more than two decades in China, ESTEVE CDMO marks a new chapter in its commitment to the country and the region. * With more than $80 million invested, the new facility brings a new generation of manufacturing capabilities, with 250 m³ of reaction volume and potential capacity of more...
2026-10-21 18:41
4991
HelpMeSee Guwahati Training Operation Reaches 51 Ophthalmologists Across Northeast India
Successful collaboration with HMS Vision Private Limited and Sri Sankaradeva Nethralaya expands access to simulation-based cataract surgical training across four Northeast states GUWAHATI, India, Oct. 21, 2026 /PRNewswire/ -- HelpMeSee and HMS Vision Private Limited, in collaboration with Sri Sa...
2026-10-21 18:30
1538
Chen Qiyu: Building on "Affordability & Reliability", Fosun Expands the Global Reach of Chinese Innovative Drugs
HONG KONG, Oct. 21, 2026 /PRNewswire/ -- On 20 October, the Sustainability Global Leaders Conference 2026 was held in Shanghai. The Conference, themed "Building a Resilient Future Together: Global Governance, Innovation-Driven Growth, and Industrial Upgrading", brought together more than 300 gues...
2026-10-21 16:52
3925
CSL appoints Deborah Waterhouse as CEO & Managing Director
MELBOURNE, Australia, Oct. 21, 2026 /PRNewswire/ -- The Board of Directors of CSL Limited (ASX:CSL; USOTC:CSLLY) today announces that it has appointed Deborah Waterhouse as Chief Executive Officer and Managing Director of CSL from 1 February 2027. The appointment was made following an extensive g...
2026-10-21 15:56
5229
Samsung Biologics Reports Third Quarter 2026 Financial Results
* Recorded Q3'26 revenue of KRW 1,490 billion and operating profit of KRW 640 billion * Plant 5 ramp-up and U.S. manufacturing operations contribute to earnings performance * Raised 2026 revenue growth guidance to 20% while advancing strategic investments in portfolio and capacity expansion...
2026-10-21 15:00
3953
Hengrui Pharma Previews ESMO Congress 2026: 64 Research Findings Highlight Continued Progress Across Innovative Pipelines to Advance Clinical Value
* 64 research findings have been accepted, including three Proffered Paper presentations and three Rapid Oral presentations, spanning more than ten areas of oncology and supportive care. * More than 10 studies have been selected to highlight the latest findings on HER2- and HER3-targeted anti...
2026-10-21 10:09
2062
AROA and Mölnlycke Partner to Expand U.S. Access to Endoform™
Exclusive co-promotion agreement combines AROA's regenerative tissue technology with Mölnlycke's wound care expertise and commercial reach AUCKLAND, New Zealand, Oct. 20, 2026 /PRNewswire/ -- Aroa Biosurgery Limited (ASX: ARX), a soft tissue regeneration company, has entered into an exclusive ag...
2026-10-21 08:00
2503
Telix Reports Third Quarter 2026 Financial Performance
MELBOURNE, Australia and INDIANAPOLIS, Oct. 21, 2026 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, "Telix") provides a financial update on its commercial and operational performance for the quarter ended September 30, 2026 (Q3 2026). Q3 2026 Highlights[1] * Group reven...
2026-10-21 06:08
5428
Lunit Highlights AI-Powered Pathology Insights Across Cancer Types at ESMO 2026
Five studies to be presented, with key research examining AI-based biomarker assessment and tumor microenvironment analysis in breast, lung and pancreatic cancers SEOUL, South Korea, Oct. 20, 2026 /PRNewswire/ -- Lunit (KRX: 328130), a leading provider of AI for cancer diagnostics and precision ...
2026-10-20 21:00
3212
Insilico Medicine and Servier Achieve First Milestone in AI-Driven R&D Collaboration, Triggering An undisclosed Milestone Payment
* Two programs under the multi-year R&D collaboration have initiated and completed target nomination since its early 2026 announcement. * Insilico reached the first R&D milestone using its proprietary Pharma.AI platform, triggering an undisclosed milestone payment from Servier. * The multi-t...
2026-10-20 21:00
3848
Metabolon Announces New Bioinformatics Application to Translate Metabolomic Biomarkers into Actionable Multiomic Hypotheses
New bioinformatics application combines curated metabolite-protein knowledge, advanced network algorithms, interactive exploration, and optional AI interpretation to generate clearer mechanistic hypotheses MORRISVILLE, N.C., Oct. 20, 2026 /PRNewswire/ -- Metabolon, Inc., the global leader in met...
2026-10-20 21:00
4493
Qualityze Earns Frost & Sullivan's 2026 North American Enabling Technology Leadership Recognition for Life Sciences QMS Software
The company is honored for its Salesforce-native, intelligence-driven platform
that combines automation, configurable workflows, and compliance-grade
processes to advance quality management in life sciences industry.
SAN ANTONIO, Oct. 20, 2026 /PRNewswire/ -- Qualityze
2026-10-20 21:00
4625
Patronus Biotech Receives Ethical Approval to Begin First-in-Human Phase 1 Trial of Three Multi-Stage Vaccines Against Malaria in Australia
Bellberry Limited Research Ethics Committee approves first-in-human study in Australia of Patronus Biotech's novel multi-stage virus-like-particle (VLP)-based malaria vaccine candidates targeting Plasmodium falciparum and Plasmodium vivax GUANGZHOU, China, Oct. 20, 2026 /PRNewswire/ -- Patronus ...
2026-10-20 20:40
2033
NeuroXT Inc. Receives U.S. FDA 510(k) Clearance for NEXT-Cue, AI Software Supporting Prognostic Assessment in Mild Cognitive Impairment
* Supports clinicians in assessing progression from mild cognitive impairment to Alzheimer's dementia within five years * NeuroXT Inc. to advance U.S. commercialization and adoption by healthcare institutions following FDA 510(k) clearance SEOUL, South Korea, Oct. 20, 2026 /PRNewswire/ -- Neu...
2026-10-20 20:00
2120
CAS collaborates with Microsoft to enable faster innovation in pharmaceutical, life sciences, and chemical industries
CAS ConnectionsSM integrates trusted human-curated scientific knowledge into Microsoft Copilot COLUMBUS, Ohio, Oct. 20, 2026 /PRNewswire/ -- CAS, a division of the American Chemical Society, today announced the availability of CAS Connections in Microsoft Copilot. The connector gives Copilot cus...
2026-10-20 20:00
2156
Hospital Authority appreciates generous donation from Sino Group and Ng Teng Fong Charitable Foundation
HONG KONG, Oct. 20, 2026 /PRNewswire/ -- The Hospital Authority (HA) today (October 20) extends its heartfelt gratitude to Sino Group and Ng Teng Fong Charitable Foundation for their generous donation of a combined total of $30 million to support the establishment of two operating theatres dedica...
2026-10-20 18:55
2708
Week's Top Stories
Most Reposted
TD Brings its Global Asset Management Businesses Under One Name
[Picked up by 1169 media titles]
2026-11-02 20:00OceanaGold Reports Third Quarter 2026 Results
[Picked up by 1130 media titles]
2026-11-05 06:52Algolia Powers Orange with AI Agents for Billing Support: NYSE Content Update
[Picked up by 1118 media titles]
2026-11-06 22:06
Overstory Launches Integrated AI Platform to Deliver First Living Model of Grid Risk
[Picked up by 1082 media titles]
2026-11-03 22:00NYSE Chair Sharon Bowen Earns Lifetime Achievement Award: NYSE Content Update
[Picked up by 1073 media titles]
2026-11-05 22:05
Most Read
Airbrush Upgrades AI Image Enhancer With 16K Output and Batch Processing for Up to 50 Images
2026-11-03 02:00
62481
Korean Derma Skincare Brand MDP+ Launches at Nordstrom
2026-11-03 00:30
27852
Home Companion Robot Mobo to Debut Globally and Open Pre-orders as AiMOGA Showcases Its Robot Family at the 2026 OMODA & JAECOO International User Summit
2026-11-07 13:49
21630
Lorikeet Dreamweaver enables businesses to give every customer an AI account manager
2026-11-04 22:00
18942